SLC1A3 and Alzheimer disease: While the molecular mechanisms underlying this discrepancy remain unclear, it is interesting to note that studies have reported that during AD pathogenesis, astrocytes exhibit decreased levels of the glutamate transporters Glast and genes involved in synapse organization, such as neuroligins and neurexins [26, 54].